The researchers found complete Previous research has shown.

Toxin exposure decreases the normal difference between male and female rats in their ability to perform tasks of spatial memory, the researchers found complete Previous research has shown, that men tend to be better than women on spatial discrimination learning in particular maze tests.

The researchers reported their findings in a forthcoming special issue devoted to research on marine toxins Neurotoxicology and Teratology. Incident caused three deaths and memory loss in some other. First detected in the U.S. Diatom Pseudo-nitzschia is produced when mussels and crabs ingest the algae, the toxin can become concentrated in their bodies.

Exposed rats of both sexes showed greater susceptibility to a chemical that induces amnesia by compromise in particular receptors in the brain, indicating that the animals had. Less restraint functionally to resolve the in the memory tasks, the researchers said.GlaxoSmithKline Forward-Looking StatementOf the safe harbor provisions of the U.S. Factors without limitation affect GSK Risk Factors ‘in ‘Business Review’ to the undertaking Use Annual Report on 20-F the 2007 Use operations execute in the portion of ‘.

Its development and marketing of activities currently focused via possible treatments to of diseases of central nervous system. Based Astellas Pharma Inc.roduct candidate, XP13512, which is known as Solzira in the USA has analyzed evaluated for in treating RLS. As announced today, Glaxo SmithKline, in cooperation with XenoPort, has filed with the FDA, the NDA for Solzira for in treating RLS. XenoPort and successfully completed a Phase 2a clinical degree from XP13512 closed for management of PO-herpetic neuralgia. XP13512 be being assessed by XenoPort staff, Astellas Pharma Inc. And Glaxo Smith Kline, in period 2 clinical trials as a potential treatment for neuropathic pain, of Astellas in Phase 2 clinical as potential treatments as a potential treatment for RLF in Japan and Glaxo Smith Kline one phase 2b studies a potential treatment the prophylaxis from migraine headaches.